CINDY JACOBS
Profile
Related Companies
Titles
Company Name
Related People
EXECUTIVE OFFICER, DIRECTOR
DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D/A
BIOTECHNOLOGY
IN VITRO + IN VIVO DIAGNOSTIC SUBSTANCES [2835]
DECLINE TO DISCLOSE
2022-11-18
D
BIOTECHNOLOGY
IN VITRO + IN VIVO DIAGNOSTIC SUBSTANCES [2835]
DECLINE TO DISCLOSE
2022-11-18
D
PHARMACEUTICALS
IN VITRO + IN VIVO DIAGNOSTIC SUBSTANCES [2835]
NO REVENUES
Equity
2009-12-24

